
- /
- Supported exchanges
- / US
- / IGMS.NASDAQ
IGM Biosciences Inc (IGMS NASDAQ) stock market data APIs
IGM Biosciences Inc Financial Data Overview
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get IGM Biosciences Inc data using free add-ons & libraries
Get IGM Biosciences Inc Fundamental Data
IGM Biosciences Inc Fundamental data includes:
- Net Revenue: 2 681 K
- EBITDA: -162 344 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-06
- EPS/Forecast: -0.45
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
IGM Biosciences Inc News

Pulse Biosciences appoints Steven T. Weber as principal accounting officer
Pulse Biosciences, Inc. (NASDAQ:PLSE) announced Monday the appointment of Steven T. Weber as Vice President of Accounting and Global Corporate Controller, effective immediately. In this role, Mr. Webe...


Concentra Group (CON) to Acquire IGM Biosciences
Concentra Group Holdings Parent, Inc. (NYSE:CON) is one of the 11 Hot New Stocks to Invest in Now.On July 1, Concentra Group Holdings Parent, Inc. (NYSE:CON) announced that it will acquire IGM Bioscie...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, SPTN, IGMS on Behalf of Shareholders
NEW YORK, July 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or bre...

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of IGM Biosciences, Inc. (NASDAQ: IGMS)
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholder...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.